Synlett 2004(2): 0247-0250  
DOI: 10.1055/s-2003-44968
LETTER
© Georg Thieme Verlag Stuttgart · New York

A Flexible Approach for the Asymmetric Synthesis of N-Protected (R)-5-Alkyl Tetramates and (R)-5-Alkyl Tetramic Acid Derivatives

Pei-Qiang Huang*, Jun Deng
Department of Chemistry and The Key Laboratory for Chemical Biology of Fujian Province, Xiamen University, Xiamen, Fujian 361005, P. R. China
Fax: +86(592)2186400; e-Mail: pqhuang@xmu.edu.cn;
Further Information

Publication History

Received 27 October 2003
Publication Date:
16 December 2003 (online)

Abstract

A flexible two-step asymmetric approach to N-protected (R)-5-alkyl tetramates and (R)-5-alkyl tetramic acid derivatives is described. The method is based on the diastereoselective alkylation of (R)-phenylglycinol derived tetramates 7 and 8, which are the first synthetic equivalents to chiral nonracemic tetramate 5-carbanionic synthons A.

23

Representative Procedure for the Alkylation of ( R )-7/8: To a solution of (R)-7 (104 mg, 0.42 mmol) in THF (8.4 mL, containing 0.37 mL of HMPA as a co-solvent) was added dropwise t-BuLi (0.67 mL, 1.5 M in pentane) at -78 ºC. After being stirred for 1 h, MeI (0.08 mL, 1.26 mmol) was added and the stirring continued for an additional 6 h at the same temperature. The reaction was quenched by sat. NH4Cl. The resulting mixture was extracted with Et2O, and the organic layers were washed with brine, dried over MgSO4 and concentrated under reduced pressure. The crude was purified by column chromatography on silica gel to give 9b (62 mg, colorless oil), its diastereomer (7 mg, pale yellow oil) (combined yield, 63%) and recovered 7 (7 mg, yield based on the recovered starting material, 68%). Compound 9b: [α]D 20 +19.4 (c 1.1, CHCl3). IR (KBr): 3374, 2981, 2934, 1657, 1625, 1340, 1221, 1029 cm-1. 1H NMR (500 MHz, CDCl3): δ = 7.40-7.20 (m, 5 H, ArH), 5.18 (dd, J = 6.4, 7.7 Hz, 1 H, D2O exchangeable, OH), 5.01 (s, 1 H, O=CCH=), 4.51 (dd, J = 3.1, 7.7 Hz, 1 H, PhCHN), 4.27 (ddd, J = 7.7, 7.7, 12.3 Hz, 1 H, HOCH 2), 4.00 (m, 3 H, CH3CH 2O and HOCH 2), 3.73 (q, J = 6.8 Hz, 1 H, CH3CHN), 1.37 (t, J = 7.1 Hz, 3 H, CH 3CH2O), 1.28 (d, J = 6.8 Hz, 3 H, CH 3CHN) ppm. 13C NMR (125 MHz, CDCl3): δ = 176.42, 173.18, 138.34, 128.80 (2 C), 127.77, 127.05 (2 C), 93.35, 67.10, 64.91, 61.90, 57.17, 15.83, 14.06 ppm. MS (ESI): m/z (%) = 262 (13) [M + H+], 244 (5) [M + H+ - H2O], 142 (100). HRMS calcd for [C15H19NO3 + H]+: 262.1438. Found: 262.1440. Minor diastereomer of 9b: [α]D 20 +17.1 (c 1.1, CHCl3). IR (KBr): 3367, 2981, 2932, 1659, 1625, 1340, 1222, 1029 cm-1. 1H NMR (500 MHz, CDCl3): δ = 7.40-7.20 (m, 5 H, ArH), 5.02 (s, 1 H, =CHC=O), 4.82 (dd, J = 3.8, 7.5 Hz, PhCHN), 4.21 (m, 1 H, HOCH 2N), 4.09 (m, 2 H, HOCH 2 and OH), 3.98 (m, 2 H, CH3CH 2O), 3.88 (q, J = 6.8 Hz, 1 H, CH3CHN), 1.37 (t, J = 7.1 Hz, 3 H, CH 3CH2O), 1.14 (d, J = 6.8 Hz, 3 H, CH 3CHN). MS (ESI): m/z (%) = 262 (100) [M + H+]. HRMS calcd for [C15H19NO3 + H]+: 262.1438. Found: 262.1432.